ArticleJTO clinical and research reports2025

Erratum to 'Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC' [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815].

Federico Cappuzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.